Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Impax Labs says FDA extends review of Parkinson's disease drug Rytary by 3 months to Jan. 21
Impax Labs says FDA extends review of Parkinson's disease drug Rytary by 3 months to Jan. 21
Impax Labs says FDA extends review of Parkinson's disease drug Rytary by 3 months to Jan. 21
Submitted by
admin
on October 12, 2012 - 12:09pm
Source:
Yahoo/AP
News Tags:
Impax Labs
FDA
Rytary
Parkinson's Disease
Headline:
Impax Labs says FDA extends review of Parkinson's disease drug Rytary by 3 months to Jan. 21
Do Not Allow Advertisers to Use My Personal information
